ABIVAX Société Anonyme (ABVX) Competitors

Disc Medicine (NASDAQ:IRON) and ABIVAX Société Anonyme (NASDAQ:ABVX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, community ranking, profitability and institutional ownership.

Is IRON or ABVX more profitable?

ABIVAX Société Anonyme's return on equity of 0.00% beat Disc Medicine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Disc Medicine	N/A	-25.24%	-23.96%
ABIVAX Société Anonyme	N/A	N/A	N/A

Does the MarketBeat Community believe in IRON or ABVX?

Disc Medicine received 49 more outperform votes than ABIVAX Société Anonyme when rated by MarketBeat users. Likewise, 86.76% of users gave Disc Medicine an outperform vote while only 76.92% of users gave ABIVAX Société Anonyme an outperform vote.

Company	Underperform	Outperform
Disc Medicine	Outperform Votes 59 86.76%	Underperform Votes 9 13.24%
ABIVAX Société Anonyme	Outperform Votes 10 76.92%	Underperform Votes 3 23.08%

Do insiders & institutionals have more ownership in IRON or ABVX?

83.7% of Disc Medicine shares are held by institutional investors. Comparatively, 47.9% of ABIVAX Société Anonyme shares are held by institutional investors. 4.2% of Disc Medicine shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has more risk and volatility, IRON or ABVX?

Disc Medicine has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, ABIVAX Société Anonyme has a beta of 0.29, suggesting that its share price is 71% less volatile than the S&P 500.

Does the media prefer IRON or ABVX?

In the previous week, Disc Medicine had 5 more articles in the media than ABIVAX Société Anonyme. MarketBeat recorded 7 mentions for Disc Medicine and 2 mentions for ABIVAX Société Anonyme. ABIVAX Société Anonyme's average media sentiment score of 1.73 beat Disc Medicine's score of 0.65 indicating that ABIVAX Société Anonyme is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Disc Medicine	6 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ABIVAX Société Anonyme	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do analysts prefer IRON or ABVX?

Disc Medicine currently has a consensus price target of $98.80, indicating a potential upside of 99.80%. ABIVAX Société Anonyme has a consensus price target of $31.00, indicating a potential upside of 436.33%. Given ABIVAX Société Anonyme's higher possible upside, analysts clearly believe ABIVAX Société Anonyme is more favorable than Disc Medicine.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Disc Medicine	0 Sell rating(s)	0 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	3.09
ABIVAX Société Anonyme	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00

Which has higher valuation & earnings, IRON or ABVX?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Disc Medicine	N/A	N/A	-$76.43M	-$3.92	-12.61
ABIVAX Société Anonyme	N/A	N/A	-$159.90M	N/A	N/A

Summary

Disc Medicine beats ABIVAX Société Anonyme on 9 of the 13 factors compared between the two stocks.